Bunge beats Q3 street estimates, maintains outlook (BG:NYSE)

Bunge reported Q3 Non-GAAP EPS of $2.56, exceeding estimates by $0.13. Revenue rose 7.4% year-over-year to $23.8B, surpassing expectations by $1.01B. The company maintained its FY2026 adjusted EPS outlook at $9.25–$9.75, but lowered its Soybean Processing outlook.

Original reporting
Published Oct 29, 2026, 10:10 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 10:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BG
Bullish
medium confidence
Mentioned
$BG
Relevance
9/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$BGBullishMed
01

Why it matters

A Q3 EPS and revenue beat with unchanged full-year adjusted EPS guidance is typically supportive, but the mention of a lowered soybean-processing outlook introduces a potential offset to the positive read-through.

02

Market read

This is a company-specific earnings/guidance update with explicit EPS, revenue, and FY outlook numbers that can drive near-term positioning.

03

What to watch

Traders may reprice the stock based on margin drivers and any commentary not captured here, especially around soybean processing demand, crush spreads, and input costs.

Relevance 9/10Novelty 8/10Timing: reported in the morning after the Q3 print

Background

The piece is a first report of Bunge’s Q3 results versus street expectations, including a maintained FY2026 adjusted EPS outlook.

Company-level read

Ticker impact

$BGBullishMedium confidence
Context

Bunge reported Q3 non-GAAP EPS of $2.56 and revenue of $23.8B, both beating estimates, and maintained FY2026 adjusted EPS outlook at $9.25–$9.75.

Expected impact

Likely upward bias as the market digests the EPS and revenue beat alongside unchanged FY adjusted EPS guidance.

Evidence & confidence

The article provides concrete Q3 beat figures and states FY2026 outlook was maintained, which typically supports near-term sentiment; it also hints at a lowered soybean-processing outlook, which can offset some optimism.

Market effects

Signals relative strength in agricultural processing earnings momentum, potentially influencing sentiment toward food/agri-processing peers.

Limited direct regional spillover beyond US-listed ag-processing supply chain sentiment.

Modest global relevance, mainly through commodity-linked processing margins rather than broad macro.

Counterpoint

The maintained headline FY range may mask weakness in soybean processing, so the market could focus on the segment outlook cut rather than the consolidated beat.

Key entities

  • Bunge

    US-listed agricultural processor reporting Q3 results and FY2026 adjusted EPS outlook.

Related articles

$BGMed

What Bunge Global (BG) Said on Its Q3 Earnings Call

Bunge Global (BG) reported Q3 earnings with mixed results. Grain merchandising gains were offset by weaker ocean freight and milling results. CEO Greg Heckman highlighted integration progress with Viterra, expecting $200M in cost savings by 2026. The company anticipates $0.50 per share from synergies in 2027. Bunge generated $2B in adjusted funds from operations, with $1.6B in discretionary cash flow.

$BGHighAI 9/10

Bunge (BG) Q3 2026 Earnings Call Transcript

Bunge (BG) reported Q3 2026 EPS of $1.64, up from $0.86 in 2025. Adjusted EPS was $2.56, with adjusted EBIT at $997M. The company maintained its full-year adjusted EPS guidance of $9.25-$9.75. Bunge highlighted progress from its Viterra combination, including cost savings and new projects. It also announced the sale of non-core sugar mills in Brazil. The company's liquidity position remains strong, with $9.7B in credit facilities.

$BGMedAI 8/10

Bunge Global 3Q 2026: Revenue $23.8B, Net income $318M, EPS $1.64— 10-Q Summary

Bunge Global reported Q3 2026 revenue of $23.8B, net income of $318M, and EPS of $1.64, up from $22.16B, $166M, and $0.84 respectively in the prior-year quarter. Nine-month net sales rose 50% to $69.7B, driven by Viterra and higher commodity prices. Soybean and softseed segment EBIT increased significantly, while sugarcane mill sale charges and Ukraine-related inventory damage weighed on results.

$BGHighAI 8/10

Bunge Q3 2026 slides: earnings beat offset by rising costs

Bunge (BG) reported Q3 2026 adjusted EPS of $2.56, beating estimates but shares fell slightly due to higher costs. The company maintained full-year guidance and highlighted benefits from Viterra integration. Adjusted segment EBIT rose 7.9% YoY, with strong performance in soybean and softseed processing, but declines in tropical oils and grain merchandising.

$BGMedAI 8/10

Bunge Q3 2026: Net Income $318 Million, Adjusted EPS $2.56

Bunge reported Q3 2026 net income of $318M, up from $166M YoY. Adjusted EPS was $2.56, and revenue reached $23.8B. The company maintained its full-year adjusted EPS outlook of $9.25-$9.75. Soybean processing improved, while Tropical Oils faced geopolitical disruptions. Bunge also announced the sale of two Brazilian sugarcane mills and progress on Viterra synergies.